Conduit Pharmaceuticals and Charles River Laboratories have announced a partnership to evaluate AZD1656, a glucokinase activator, in a preclinical model of systemic lupus erythematosus (SLE).

There are multiple chapters near you. Select your preferred chapter.

We are looking forward to our national education event -- Lupus & You: Answers. Advocacy. Action. This free educational series will bring you the latest in lupus research, disease management, and ...